nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—Adenosine monophosphate—Cladribine—multiple sclerosis	0.213	0.357	CrCrCtD
Tenofovir—Adenosine—Cladribine—multiple sclerosis	0.191	0.321	CrCrCtD
Tenofovir—Vidarabine—Cladribine—multiple sclerosis	0.191	0.321	CrCrCtD
Tenofovir—ABCC10—Methotrexate—multiple sclerosis	0.0778	0.38	CbGbCtD
Tenofovir—ABCC4—Methotrexate—multiple sclerosis	0.0374	0.183	CbGbCtD
Tenofovir—ABCC2—Dexamethasone—multiple sclerosis	0.0277	0.135	CbGbCtD
Tenofovir—SLC22A8—Methotrexate—multiple sclerosis	0.0234	0.114	CbGbCtD
Tenofovir—ABCC2—Methotrexate—multiple sclerosis	0.0222	0.109	CbGbCtD
Tenofovir—SLC22A6—Methotrexate—multiple sclerosis	0.0163	0.0795	CbGbCtD
Tenofovir—NME2—Nucleotide Metabolism—SRM—multiple sclerosis	0.00812	0.148	CbGpPWpGaD
Tenofovir—AK2—Synthesis and interconversion of nucleotide di- and triphosphates—RRM1—multiple sclerosis	0.00653	0.119	CbGpPWpGaD
Tenofovir—NME2—pineal body—multiple sclerosis	0.0065	0.177	CbGeAlD
Tenofovir—S-Adenosylmethionine—SRM—multiple sclerosis	0.00507	1	CrCbGaD
Tenofovir—NME2—Synthesis and interconversion of nucleotide di- and triphosphates—RRM1—multiple sclerosis	0.00453	0.0824	CbGpPWpGaD
Tenofovir—NME2—Nucleotide Metabolism—RRM1—multiple sclerosis	0.00434	0.0789	CbGpPWpGaD
Tenofovir—NME1—Synthesis and interconversion of nucleotide di- and triphosphates—RRM1—multiple sclerosis	0.00343	0.0624	CbGpPWpGaD
Tenofovir—NME2—brainstem—multiple sclerosis	0.00203	0.0552	CbGeAlD
Tenofovir—AK2—Nucleotide metabolism—RRM1—multiple sclerosis	0.00202	0.0368	CbGpPWpGaD
Tenofovir—AK4—retina—multiple sclerosis	0.002	0.0545	CbGeAlD
Tenofovir—NME2—retina—multiple sclerosis	0.00196	0.0532	CbGeAlD
Tenofovir—AK4—medulla oblongata—multiple sclerosis	0.00145	0.0394	CbGeAlD
Tenofovir—NME2—Nucleotide metabolism—RRM1—multiple sclerosis	0.0014	0.0255	CbGpPWpGaD
Tenofovir—AK2—cerebellum—multiple sclerosis	0.00138	0.0376	CbGeAlD
Tenofovir—AK4—midbrain—multiple sclerosis	0.00132	0.036	CbGeAlD
Tenofovir—AK4—spinal cord—multiple sclerosis	0.00129	0.0351	CbGeAlD
Tenofovir—NME1—nervous system—multiple sclerosis	0.00113	0.0307	CbGeAlD
Tenofovir—AK2—brain—multiple sclerosis	0.00112	0.0306	CbGeAlD
Tenofovir—AK4—nervous system—multiple sclerosis	0.00109	0.0296	CbGeAlD
Tenofovir—NME1—central nervous system—multiple sclerosis	0.00109	0.0296	CbGeAlD
Tenofovir—NME2—nervous system—multiple sclerosis	0.00106	0.0289	CbGeAlD
Tenofovir—NME1—cerebellum—multiple sclerosis	0.00106	0.0289	CbGeAlD
Tenofovir—NME1—Nucleotide metabolism—RRM1—multiple sclerosis	0.00106	0.0193	CbGpPWpGaD
Tenofovir—AK4—central nervous system—multiple sclerosis	0.00105	0.0285	CbGeAlD
Tenofovir—AK4—cerebellum—multiple sclerosis	0.00102	0.0278	CbGeAlD
Tenofovir—NME2—central nervous system—multiple sclerosis	0.00102	0.0278	CbGeAlD
Tenofovir—NME2—cerebellum—multiple sclerosis	0.001	0.0272	CbGeAlD
Tenofovir—NME1—Arf6 trafficking events—ITGA4—multiple sclerosis	0.000872	0.0159	CbGpPWpGaD
Tenofovir—NME1—brain—multiple sclerosis	0.000863	0.0235	CbGeAlD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000859	0.0156	CbGpPWpGaD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000859	0.0156	CbGpPWpGaD
Tenofovir—AK4—brain—multiple sclerosis	0.000831	0.0226	CbGeAlD
Tenofovir—NME2—brain—multiple sclerosis	0.000812	0.0221	CbGeAlD
Tenofovir—ABCC4—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000791	0.0144	CbGpPWpGaD
Tenofovir—ABCC2—Irinotecan Pathway—BCHE—multiple sclerosis	0.000761	0.0138	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—multiple sclerosis	0.000689	0.0125	CbGpPWpGaD
Tenofovir—ABCC10—medulla oblongata—multiple sclerosis	0.000687	0.0187	CbGeAlD
Tenofovir—NME1—Arf6 downstream pathway—MAPK1—multiple sclerosis	0.000666	0.0121	CbGpPWpGaD
Tenofovir—ABCC10—midbrain—multiple sclerosis	0.000628	0.0171	CbGeAlD
Tenofovir—ABCC10—spinal cord—multiple sclerosis	0.000612	0.0167	CbGeAlD
Tenofovir—ABCC4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00058	0.0106	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—AHI1—multiple sclerosis	0.000578	0.0105	CbGpPWpGaD
Tenofovir—SLC22A6—brain—multiple sclerosis	0.000542	0.0147	CbGeAlD
Tenofovir—NME1—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000525	0.254	CbGdCrCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000519	0.00944	CbGpPWpGaD
Tenofovir—NME1—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000517	0.25	CbGdCrCtD
Tenofovir—NME1—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000517	0.25	CbGdCrCtD
Tenofovir—NME1—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000505	0.245	CbGdCrCtD
Tenofovir—ABCC2—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000489	0.0089	CbGpPWpGaD
Tenofovir—ABCC10—cerebellum—multiple sclerosis	0.000486	0.0132	CbGeAlD
Tenofovir—ABCC4—nervous system—multiple sclerosis	0.000428	0.0116	CbGeAlD
Tenofovir—SLC22A8—nervous system—multiple sclerosis	0.000425	0.0115	CbGeAlD
Tenofovir—ABCC4—Platelet degranulation—PLEK—multiple sclerosis	0.000419	0.00762	CbGpPWpGaD
Tenofovir—ABCC4—central nervous system—multiple sclerosis	0.000412	0.0112	CbGeAlD
Tenofovir—SLC22A8—central nervous system—multiple sclerosis	0.000409	0.0111	CbGeAlD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000399	0.00726	CbGpPWpGaD
Tenofovir—ABCC10—brain—multiple sclerosis	0.000394	0.0107	CbGeAlD
Tenofovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000375	0.00681	CbGpPWpGaD
Tenofovir—AK2—Metabolism—SRM—multiple sclerosis	0.000344	0.00626	CbGpPWpGaD
Tenofovir—ABCC4—brain—multiple sclerosis	0.000327	0.0089	CbGeAlD
Tenofovir—SLC22A8—brain—multiple sclerosis	0.000325	0.00883	CbGeAlD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000323	0.00587	CbGpPWpGaD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000323	0.00587	CbGpPWpGaD
Tenofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000313	0.00569	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.0003	0.00547	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—MMP9—multiple sclerosis	0.000288	0.00524	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000284	0.00517	CbGpPWpGaD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000281	0.00511	CbGpPWpGaD
Tenofovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000262	0.00476	CbGpPWpGaD
Tenofovir—Polyuria—Methotrexate—multiple sclerosis	0.000245	0.00243	CcSEcCtD
Tenofovir—AK2—Metabolism—CYP24A1—multiple sclerosis	0.000242	0.00441	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CYP27B1—multiple sclerosis	0.000242	0.00441	CbGpPWpGaD
Tenofovir—Sweating—Methylprednisolone—multiple sclerosis	0.00024	0.00238	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000239	0.00237	CcSEcCtD
Tenofovir—NME2—Metabolism—SRM—multiple sclerosis	0.000238	0.00434	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—MYC—multiple sclerosis	0.000238	0.00433	CbGpPWpGaD
Tenofovir—Hypersensitivity—Cladribine—multiple sclerosis	0.000238	0.00236	CcSEcCtD
Tenofovir—Hypokalaemia—Prednisone—multiple sclerosis	0.000234	0.00232	CcSEcCtD
Tenofovir—Renal failure acute—Methotrexate—multiple sclerosis	0.000233	0.00231	CcSEcCtD
Tenofovir—Asthenia—Cladribine—multiple sclerosis	0.000232	0.0023	CcSEcCtD
Tenofovir—Weight decreased—Betamethasone—multiple sclerosis	0.000231	0.00229	CcSEcCtD
Tenofovir—Weight decreased—Dexamethasone—multiple sclerosis	0.000231	0.00229	CcSEcCtD
Tenofovir—Hyperglycaemia—Betamethasone—multiple sclerosis	0.00023	0.00228	CcSEcCtD
Tenofovir—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.00023	0.00228	CcSEcCtD
Tenofovir—Pruritus—Cladribine—multiple sclerosis	0.000228	0.00226	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000228	0.00415	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000228	0.00414	CbGpPWpGaD
Tenofovir—Muscular weakness—Prednisone—multiple sclerosis	0.000227	0.00225	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000227	0.00225	CcSEcCtD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000225	0.00409	CbGpPWpGaD
Tenofovir—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000223	0.00221	CcSEcCtD
Tenofovir—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000223	0.00221	CcSEcCtD
Tenofovir—AK2—Metabolism—GPC5—multiple sclerosis	0.000222	0.00403	CbGpPWpGaD
Tenofovir—Chest pain—Mitoxantrone—multiple sclerosis	0.000221	0.00219	CcSEcCtD
Tenofovir—Arthralgia—Mitoxantrone—multiple sclerosis	0.000221	0.00219	CcSEcCtD
Tenofovir—Myalgia—Mitoxantrone—multiple sclerosis	0.000221	0.00219	CcSEcCtD
Tenofovir—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000221	0.00219	CcSEcCtD
Tenofovir—Diarrhoea—Cladribine—multiple sclerosis	0.000221	0.00219	CcSEcCtD
Tenofovir—Anxiety—Mitoxantrone—multiple sclerosis	0.000221	0.00219	CcSEcCtD
Tenofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000218	0.00397	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MMP9—multiple sclerosis	0.000218	0.00397	CbGpPWpGaD
Tenofovir—Pancreatitis—Prednisone—multiple sclerosis	0.000218	0.00216	CcSEcCtD
Tenofovir—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000215	0.00213	CcSEcCtD
Tenofovir—Dizziness—Cladribine—multiple sclerosis	0.000213	0.00212	CcSEcCtD
Tenofovir—Body temperature increased—Azathioprine—multiple sclerosis	0.000207	0.00206	CcSEcCtD
Tenofovir—Abdominal pain—Azathioprine—multiple sclerosis	0.000207	0.00206	CcSEcCtD
Tenofovir—Skin disorder—Mitoxantrone—multiple sclerosis	0.000206	0.00204	CcSEcCtD
Tenofovir—Vomiting—Cladribine—multiple sclerosis	0.000205	0.00203	CcSEcCtD
Tenofovir—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000205	0.00203	CcSEcCtD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000205	0.00372	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000205	0.00372	CbGpPWpGaD
Tenofovir—Rash—Cladribine—multiple sclerosis	0.000203	0.00202	CcSEcCtD
Tenofovir—Dermatitis—Cladribine—multiple sclerosis	0.000203	0.00202	CcSEcCtD
Tenofovir—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000203	0.00201	CcSEcCtD
Tenofovir—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000203	0.00201	CcSEcCtD
Tenofovir—Anorexia—Mitoxantrone—multiple sclerosis	0.000202	0.002	CcSEcCtD
Tenofovir—Headache—Cladribine—multiple sclerosis	0.000202	0.002	CcSEcCtD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000202	0.00368	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000202	0.00368	CbGpPWpGaD
Tenofovir—Weight decreased—Prednisone—multiple sclerosis	0.000201	0.00199	CcSEcCtD
Tenofovir—Hyperglycaemia—Prednisone—multiple sclerosis	0.000201	0.00199	CcSEcCtD
Tenofovir—Depression—Prednisone—multiple sclerosis	0.000198	0.00196	CcSEcCtD
Tenofovir—Mental disorder—Methylprednisolone—multiple sclerosis	0.000197	0.00195	CcSEcCtD
Tenofovir—Malnutrition—Methylprednisolone—multiple sclerosis	0.000196	0.00194	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000195	0.00355	CbGpPWpGaD
Tenofovir—Angioedema—Prednisolone—multiple sclerosis	0.000195	0.00193	CcSEcCtD
Tenofovir—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000194	0.00193	CcSEcCtD
Tenofovir—Hypersensitivity—Azathioprine—multiple sclerosis	0.000193	0.00192	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000193	0.00192	CcSEcCtD
Tenofovir—Nausea—Cladribine—multiple sclerosis	0.000192	0.0019	CcSEcCtD
Tenofovir—Back pain—Triamcinolone—multiple sclerosis	0.00019	0.00188	CcSEcCtD
Tenofovir—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000189	0.00187	CcSEcCtD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000187	0.00341	CbGpPWpGaD
Tenofovir—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000187	0.00185	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000186	0.00338	CbGpPWpGaD
Tenofovir—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000184	0.00183	CcSEcCtD
Tenofovir—AK2—Metabolism—RRM1—multiple sclerosis	0.000184	0.00334	CbGpPWpGaD
Tenofovir—Fatigue—Mitoxantrone—multiple sclerosis	0.000183	0.00181	CcSEcCtD
Tenofovir—Pancreatitis—Methotrexate—multiple sclerosis	0.000182	0.00181	CcSEcCtD
Tenofovir—Pain—Mitoxantrone—multiple sclerosis	0.000181	0.0018	CcSEcCtD
Tenofovir—NME1—Metabolism—SRM—multiple sclerosis	0.000181	0.00329	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MYC—multiple sclerosis	0.00018	0.00328	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00018	0.00327	CbGpPWpGaD
Tenofovir—Diarrhoea—Azathioprine—multiple sclerosis	0.00018	0.00178	CcSEcCtD
Tenofovir—Angioedema—Triamcinolone—multiple sclerosis	0.000179	0.00178	CcSEcCtD
Tenofovir—Angioedema—Methylprednisolone—multiple sclerosis	0.000179	0.00177	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000176	0.00319	CbGpPWpGaD
Tenofovir—Connective tissue disorder—Prednisone—multiple sclerosis	0.000175	0.00173	CcSEcCtD
Tenofovir—Dizziness—Azathioprine—multiple sclerosis	0.000174	0.00172	CcSEcCtD
Tenofovir—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000173	0.00172	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000173	0.00171	CcSEcCtD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00017	0.0031	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000168	0.00167	CcSEcCtD
Tenofovir—NME2—Metabolism—CYP27B1—multiple sclerosis	0.000168	0.00306	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP24A1—multiple sclerosis	0.000168	0.00306	CbGpPWpGaD
Tenofovir—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000168	0.00166	CcSEcCtD
Tenofovir—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000168	0.00166	CcSEcCtD
Tenofovir—Myalgia—Triamcinolone—multiple sclerosis	0.000167	0.00165	CcSEcCtD
Tenofovir—Vomiting—Azathioprine—multiple sclerosis	0.000167	0.00165	CcSEcCtD
Tenofovir—Pneumonia—Methotrexate—multiple sclerosis	0.000167	0.00165	CcSEcCtD
Tenofovir—Myalgia—Methylprednisolone—multiple sclerosis	0.000167	0.00165	CcSEcCtD
Tenofovir—Arthralgia—Methylprednisolone—multiple sclerosis	0.000167	0.00165	CcSEcCtD
Tenofovir—Anxiety—Methylprednisolone—multiple sclerosis	0.000166	0.00165	CcSEcCtD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000166	0.00302	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000166	0.00302	CbGpPWpGaD
Tenofovir—Infestation—Methotrexate—multiple sclerosis	0.000166	0.00164	CcSEcCtD
Tenofovir—Infestation NOS—Methotrexate—multiple sclerosis	0.000166	0.00164	CcSEcCtD
Tenofovir—Rash—Azathioprine—multiple sclerosis	0.000165	0.00164	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000165	0.00164	CcSEcCtD
Tenofovir—Dermatitis—Azathioprine—multiple sclerosis	0.000165	0.00164	CcSEcCtD
Tenofovir—Depression—Methotrexate—multiple sclerosis	0.000165	0.00164	CcSEcCtD
Tenofovir—Headache—Azathioprine—multiple sclerosis	0.000164	0.00163	CcSEcCtD
Tenofovir—Renal failure—Methotrexate—multiple sclerosis	0.000163	0.00161	CcSEcCtD
Tenofovir—Angioedema—Dexamethasone—multiple sclerosis	0.000163	0.00161	CcSEcCtD
Tenofovir—Angioedema—Betamethasone—multiple sclerosis	0.000163	0.00161	CcSEcCtD
Tenofovir—Immune system disorder—Prednisone—multiple sclerosis	0.000161	0.00159	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000159	0.00289	CbGpPWpGaD
Tenofovir—Sweating—Methotrexate—multiple sclerosis	0.000159	0.00157	CcSEcCtD
Tenofovir—Haematuria—Methotrexate—multiple sclerosis	0.000158	0.00157	CcSEcCtD
Tenofovir—Insomnia—Prednisolone—multiple sclerosis	0.000157	0.00156	CcSEcCtD
Tenofovir—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000157	0.00155	CcSEcCtD
Tenofovir—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000157	0.00155	CcSEcCtD
Tenofovir—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000156	0.00155	CcSEcCtD
Tenofovir—Mental disorder—Prednisone—multiple sclerosis	0.000156	0.00155	CcSEcCtD
Tenofovir—Nausea—Azathioprine—multiple sclerosis	0.000156	0.00155	CcSEcCtD
Tenofovir—Skin disorder—Methylprednisolone—multiple sclerosis	0.000155	0.00154	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—SELPLG—multiple sclerosis	0.000155	0.00282	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MERTK—multiple sclerosis	0.000155	0.00282	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CD58—multiple sclerosis	0.000155	0.00282	CbGpPWpGaD
Tenofovir—Malnutrition—Prednisone—multiple sclerosis	0.000155	0.00154	CcSEcCtD
Tenofovir—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000155	0.00153	CcSEcCtD
Tenofovir—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000154	0.00153	CcSEcCtD
Tenofovir—NME2—Metabolism—GPC5—multiple sclerosis	0.000154	0.00279	CbGpPWpGaD
Tenofovir—Asthenia—Mitoxantrone—multiple sclerosis	0.000152	0.00151	CcSEcCtD
Tenofovir—Myalgia—Dexamethasone—multiple sclerosis	0.000151	0.0015	CcSEcCtD
Tenofovir—Myalgia—Betamethasone—multiple sclerosis	0.000151	0.0015	CcSEcCtD
Tenofovir—Anxiety—Betamethasone—multiple sclerosis	0.000151	0.0015	CcSEcCtD
Tenofovir—Anxiety—Dexamethasone—multiple sclerosis	0.000151	0.0015	CcSEcCtD
Tenofovir—Pain—Prednisolone—multiple sclerosis	0.000149	0.00148	CcSEcCtD
Tenofovir—Hepatitis—Methotrexate—multiple sclerosis	0.000149	0.00147	CcSEcCtD
Tenofovir—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000147	0.00146	CcSEcCtD
Tenofovir—Urethral disorder—Methotrexate—multiple sclerosis	0.000146	0.00145	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000146	0.00145	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000145	0.00144	CcSEcCtD
Tenofovir—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000145	0.00144	CcSEcCtD
Tenofovir—Insomnia—Triamcinolone—multiple sclerosis	0.000145	0.00143	CcSEcCtD
Tenofovir—Insomnia—Methylprednisolone—multiple sclerosis	0.000144	0.00143	CcSEcCtD
Tenofovir—Dyspnoea—Triamcinolone—multiple sclerosis	0.000143	0.00141	CcSEcCtD
Tenofovir—Nervous system disorder—Betamethasone—multiple sclerosis	0.000142	0.00141	CcSEcCtD
Tenofovir—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000142	0.00141	CcSEcCtD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000142	0.00258	CbGpPWpGaD
Tenofovir—Angioedema—Prednisone—multiple sclerosis	0.000142	0.0014	CcSEcCtD
Tenofovir—Dyspepsia—Triamcinolone—multiple sclerosis	0.000141	0.0014	CcSEcCtD
Tenofovir—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000141	0.00139	CcSEcCtD
Tenofovir—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00014	0.00139	CcSEcCtD
Tenofovir—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00014	0.00139	CcSEcCtD
Tenofovir—Anorexia—Betamethasone—multiple sclerosis	0.000138	0.00137	CcSEcCtD
Tenofovir—Anorexia—Dexamethasone—multiple sclerosis	0.000138	0.00137	CcSEcCtD
Tenofovir—Fatigue—Triamcinolone—multiple sclerosis	0.000138	0.00137	CcSEcCtD
Tenofovir—Fatigue—Methylprednisolone—multiple sclerosis	0.000138	0.00136	CcSEcCtD
Tenofovir—Pain—Triamcinolone—multiple sclerosis	0.000137	0.00136	CcSEcCtD
Tenofovir—Vomiting—Mitoxantrone—multiple sclerosis	0.000135	0.00134	CcSEcCtD
Tenofovir—Immune system disorder—Methotrexate—multiple sclerosis	0.000134	0.00133	CcSEcCtD
Tenofovir—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000134	0.00133	CcSEcCtD
Tenofovir—Rash—Mitoxantrone—multiple sclerosis	0.000134	0.00133	CcSEcCtD
Tenofovir—Dermatitis—Mitoxantrone—multiple sclerosis	0.000134	0.00132	CcSEcCtD
Tenofovir—Headache—Mitoxantrone—multiple sclerosis	0.000133	0.00132	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000132	0.00131	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000132	0.00131	CcSEcCtD
Tenofovir—Arthralgia—Prednisone—multiple sclerosis	0.000132	0.00131	CcSEcCtD
Tenofovir—Myalgia—Prednisone—multiple sclerosis	0.000132	0.00131	CcSEcCtD
Tenofovir—Anxiety—Prednisone—multiple sclerosis	0.000131	0.0013	CcSEcCtD
Tenofovir—Insomnia—Betamethasone—multiple sclerosis	0.000131	0.0013	CcSEcCtD
Tenofovir—Insomnia—Dexamethasone—multiple sclerosis	0.000131	0.0013	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000131	0.0013	CcSEcCtD
Tenofovir—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000131	0.00129	CcSEcCtD
Tenofovir—Mental disorder—Methotrexate—multiple sclerosis	0.00013	0.00129	CcSEcCtD
Tenofovir—Malnutrition—Methotrexate—multiple sclerosis	0.00013	0.00128	CcSEcCtD
Tenofovir—Hypersensitivity—Prednisolone—multiple sclerosis	0.000128	0.00127	CcSEcCtD
Tenofovir—Dyspepsia—Betamethasone—multiple sclerosis	0.000128	0.00127	CcSEcCtD
Tenofovir—Dyspepsia—Dexamethasone—multiple sclerosis	0.000128	0.00127	CcSEcCtD
Tenofovir—NME2—Metabolism—RRM1—multiple sclerosis	0.000127	0.00232	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP27B1—multiple sclerosis	0.000127	0.00232	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP24A1—multiple sclerosis	0.000127	0.00232	CbGpPWpGaD
Tenofovir—Body temperature increased—Triamcinolone—multiple sclerosis	0.000127	0.00125	CcSEcCtD
Tenofovir—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000126	0.00125	CcSEcCtD
Tenofovir—Decreased appetite—Betamethasone—multiple sclerosis	0.000126	0.00125	CcSEcCtD
Tenofovir—Decreased appetite—Dexamethasone—multiple sclerosis	0.000126	0.00125	CcSEcCtD
Tenofovir—Nausea—Mitoxantrone—multiple sclerosis	0.000126	0.00125	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000125	0.00124	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000125	0.00124	CcSEcCtD
Tenofovir—Back pain—Methotrexate—multiple sclerosis	0.000125	0.00124	CcSEcCtD
Tenofovir—Fatigue—Betamethasone—multiple sclerosis	0.000125	0.00124	CcSEcCtD
Tenofovir—Fatigue—Dexamethasone—multiple sclerosis	0.000125	0.00124	CcSEcCtD
Tenofovir—Pain—Dexamethasone—multiple sclerosis	0.000124	0.00123	CcSEcCtD
Tenofovir—Pain—Betamethasone—multiple sclerosis	0.000124	0.00123	CcSEcCtD
Tenofovir—Nervous system disorder—Prednisone—multiple sclerosis	0.000124	0.00123	CcSEcCtD
Tenofovir—Skin disorder—Prednisone—multiple sclerosis	0.000123	0.00122	CcSEcCtD
Tenofovir—Hyperhidrosis—Prednisone—multiple sclerosis	0.000122	0.00121	CcSEcCtD
Tenofovir—Anorexia—Prednisone—multiple sclerosis	0.000121	0.00119	CcSEcCtD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000119	0.00216	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000119	0.00118	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000119	0.00118	CcSEcCtD
Tenofovir—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000118	0.00117	CcSEcCtD
Tenofovir—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000118	0.00117	CcSEcCtD
Tenofovir—NME1—Metabolism—GPC5—multiple sclerosis	0.000116	0.00212	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Tenofovir—Dizziness—Prednisolone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Tenofovir—Asthenia—Triamcinolone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Tenofovir—Body temperature increased—Dexamethasone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Tenofovir—Body temperature increased—Betamethasone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Tenofovir—Abdominal pain—Betamethasone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Tenofovir—Abdominal pain—Dexamethasone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Tenofovir—Asthenia—Methylprednisolone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Tenofovir—Insomnia—Prednisone—multiple sclerosis	0.000114	0.00113	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000114	0.00208	CbGpPWpGaD
Tenofovir—Pruritus—Triamcinolone—multiple sclerosis	0.000113	0.00112	CcSEcCtD
Tenofovir—Pruritus—Methylprednisolone—multiple sclerosis	0.000113	0.00112	CcSEcCtD
Tenofovir—Dyspepsia—Prednisone—multiple sclerosis	0.000111	0.0011	CcSEcCtD
Tenofovir—Arthralgia—Methotrexate—multiple sclerosis	0.00011	0.00109	CcSEcCtD
Tenofovir—Chest pain—Methotrexate—multiple sclerosis	0.00011	0.00109	CcSEcCtD
Tenofovir—Myalgia—Methotrexate—multiple sclerosis	0.00011	0.00109	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.00011	0.00201	CbGpPWpGaD
Tenofovir—Decreased appetite—Prednisone—multiple sclerosis	0.00011	0.00109	CcSEcCtD
Tenofovir—Rash—Prednisolone—multiple sclerosis	0.00011	0.00109	CcSEcCtD
Tenofovir—Dermatitis—Prednisolone—multiple sclerosis	0.00011	0.00109	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000109	0.00109	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000109	0.00199	CbGpPWpGaD
Tenofovir—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000109	0.00108	CcSEcCtD
Tenofovir—Fatigue—Prednisone—multiple sclerosis	0.000109	0.00108	CcSEcCtD
Tenofovir—Headache—Prednisolone—multiple sclerosis	0.000109	0.00108	CcSEcCtD
Tenofovir—Dizziness—Triamcinolone—multiple sclerosis	0.000106	0.00105	CcSEcCtD
Tenofovir—Dizziness—Methylprednisolone—multiple sclerosis	0.000106	0.00105	CcSEcCtD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000106	0.00192	CbGpPWpGaD
Tenofovir—AK2—Metabolism—BCHE—multiple sclerosis	0.000105	0.00192	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—ALB—multiple sclerosis	0.000105	0.00192	CbGpPWpGaD
Tenofovir—Asthenia—Betamethasone—multiple sclerosis	0.000104	0.00103	CcSEcCtD
Tenofovir—Asthenia—Dexamethasone—multiple sclerosis	0.000104	0.00103	CcSEcCtD
Tenofovir—Nervous system disorder—Methotrexate—multiple sclerosis	0.000104	0.00103	CcSEcCtD
Tenofovir—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000103	0.00103	CcSEcCtD
Tenofovir—Nausea—Prednisolone—multiple sclerosis	0.000103	0.00102	CcSEcCtD
Tenofovir—Pruritus—Dexamethasone—multiple sclerosis	0.000103	0.00102	CcSEcCtD
Tenofovir—Pruritus—Betamethasone—multiple sclerosis	0.000103	0.00102	CcSEcCtD
Tenofovir—Skin disorder—Methotrexate—multiple sclerosis	0.000103	0.00102	CcSEcCtD
Tenofovir—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000102	0.00101	CcSEcCtD
Tenofovir—Vomiting—Triamcinolone—multiple sclerosis	0.000102	0.00101	CcSEcCtD
Tenofovir—Vomiting—Methylprednisolone—multiple sclerosis	0.000102	0.00101	CcSEcCtD
Tenofovir—Rash—Triamcinolone—multiple sclerosis	0.000101	0.001	CcSEcCtD
Tenofovir—Dermatitis—Triamcinolone—multiple sclerosis	0.000101	0.000999	CcSEcCtD
Tenofovir—Anorexia—Methotrexate—multiple sclerosis	0.000101	0.000999	CcSEcCtD
Tenofovir—Rash—Methylprednisolone—multiple sclerosis	0.000101	0.000998	CcSEcCtD
Tenofovir—Dermatitis—Methylprednisolone—multiple sclerosis	0.000101	0.000997	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	0.0001	0.00183	CbGpPWpGaD
Tenofovir—Headache—Triamcinolone—multiple sclerosis	0.0001	0.000994	CcSEcCtD
Tenofovir—Headache—Methylprednisolone—multiple sclerosis	0.0001	0.000992	CcSEcCtD
Tenofovir—Abdominal pain—Prednisone—multiple sclerosis	0.0001	0.000991	CcSEcCtD
Tenofovir—Body temperature increased—Prednisone—multiple sclerosis	0.0001	0.000991	CcSEcCtD
Tenofovir—Diarrhoea—Betamethasone—multiple sclerosis	9.94e-05	0.000985	CcSEcCtD
Tenofovir—Diarrhoea—Dexamethasone—multiple sclerosis	9.94e-05	0.000985	CcSEcCtD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	9.93e-05	0.00181	CbGpPWpGaD
Tenofovir—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	9.74e-05	0.00177	CbGpPWpGaD
Tenofovir—NME1—Metabolism—RRM1—multiple sclerosis	9.65e-05	0.00175	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	9.63e-05	0.000955	CcSEcCtD
Tenofovir—Dizziness—Dexamethasone—multiple sclerosis	9.6e-05	0.000952	CcSEcCtD
Tenofovir—Dizziness—Betamethasone—multiple sclerosis	9.6e-05	0.000952	CcSEcCtD
Tenofovir—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	9.59e-05	0.00174	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PLEK—multiple sclerosis	9.58e-05	0.00174	CbGpPWpGaD
Tenofovir—Insomnia—Methotrexate—multiple sclerosis	9.56e-05	0.000948	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.52e-05	0.00173	CbGpPWpGaD
Tenofovir—Nausea—Triamcinolone—multiple sclerosis	9.51e-05	0.000942	CcSEcCtD
Tenofovir—Nausea—Methylprednisolone—multiple sclerosis	9.49e-05	0.00094	CcSEcCtD
Tenofovir—Dyspnoea—Methotrexate—multiple sclerosis	9.42e-05	0.000934	CcSEcCtD
Tenofovir—Hypersensitivity—Prednisone—multiple sclerosis	9.32e-05	0.000924	CcSEcCtD
Tenofovir—Dyspepsia—Methotrexate—multiple sclerosis	9.3e-05	0.000922	CcSEcCtD
Tenofovir—Vomiting—Betamethasone—multiple sclerosis	9.23e-05	0.000915	CcSEcCtD
Tenofovir—Vomiting—Dexamethasone—multiple sclerosis	9.23e-05	0.000915	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.23e-05	0.00168	CbGpPWpGaD
Tenofovir—Decreased appetite—Methotrexate—multiple sclerosis	9.19e-05	0.000911	CcSEcCtD
Tenofovir—Rash—Betamethasone—multiple sclerosis	9.16e-05	0.000908	CcSEcCtD
Tenofovir—Rash—Dexamethasone—multiple sclerosis	9.16e-05	0.000908	CcSEcCtD
Tenofovir—Dermatitis—Betamethasone—multiple sclerosis	9.15e-05	0.000907	CcSEcCtD
Tenofovir—Dermatitis—Dexamethasone—multiple sclerosis	9.15e-05	0.000907	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.12e-05	0.000904	CcSEcCtD
Tenofovir—Fatigue—Methotrexate—multiple sclerosis	9.11e-05	0.000903	CcSEcCtD
Tenofovir—Headache—Dexamethasone—multiple sclerosis	9.1e-05	0.000902	CcSEcCtD
Tenofovir—Headache—Betamethasone—multiple sclerosis	9.1e-05	0.000902	CcSEcCtD
Tenofovir—Asthenia—Prednisone—multiple sclerosis	9.07e-05	0.000899	CcSEcCtD
Tenofovir—Pain—Methotrexate—multiple sclerosis	9.04e-05	0.000896	CcSEcCtD
Tenofovir—Pruritus—Prednisone—multiple sclerosis	8.95e-05	0.000887	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.9e-05	0.00162	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.88e-05	0.00162	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	8.82e-05	0.0016	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	8.82e-05	0.0016	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.71e-05	0.00158	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.7e-05	0.00158	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.7e-05	0.00158	CbGpPWpGaD
Tenofovir—Diarrhoea—Prednisone—multiple sclerosis	8.65e-05	0.000858	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.65e-05	0.00157	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.64e-05	0.000857	CcSEcCtD
Tenofovir—Nausea—Dexamethasone—multiple sclerosis	8.63e-05	0.000855	CcSEcCtD
Tenofovir—Nausea—Betamethasone—multiple sclerosis	8.63e-05	0.000855	CcSEcCtD
Tenofovir—Dizziness—Prednisone—multiple sclerosis	8.36e-05	0.000829	CcSEcCtD
Tenofovir—Body temperature increased—Methotrexate—multiple sclerosis	8.36e-05	0.000828	CcSEcCtD
Tenofovir—Abdominal pain—Methotrexate—multiple sclerosis	8.36e-05	0.000828	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.29e-05	0.00151	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.29e-05	0.00151	CbGpPWpGaD
Tenofovir—Vomiting—Prednisone—multiple sclerosis	8.04e-05	0.000797	CcSEcCtD
Tenofovir—Rash—Prednisone—multiple sclerosis	7.97e-05	0.00079	CcSEcCtD
Tenofovir—Dermatitis—Prednisone—multiple sclerosis	7.97e-05	0.00079	CcSEcCtD
Tenofovir—Headache—Prednisone—multiple sclerosis	7.92e-05	0.000785	CcSEcCtD
Tenofovir—Hypersensitivity—Methotrexate—multiple sclerosis	7.79e-05	0.000772	CcSEcCtD
Tenofovir—Asthenia—Methotrexate—multiple sclerosis	7.58e-05	0.000752	CcSEcCtD
Tenofovir—Nausea—Prednisone—multiple sclerosis	7.51e-05	0.000745	CcSEcCtD
Tenofovir—Pruritus—Methotrexate—multiple sclerosis	7.48e-05	0.000741	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—CCL2—multiple sclerosis	7.31e-05	0.00133	CbGpPWpGaD
Tenofovir—NME2—Metabolism—BCHE—multiple sclerosis	7.31e-05	0.00133	CbGpPWpGaD
Tenofovir—Diarrhoea—Methotrexate—multiple sclerosis	7.23e-05	0.000717	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.22e-05	0.00131	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.99e-05	0.00127	CbGpPWpGaD
Tenofovir—Dizziness—Methotrexate—multiple sclerosis	6.99e-05	0.000693	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.84e-05	0.00124	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SELE—multiple sclerosis	6.75e-05	0.00123	CbGpPWpGaD
Tenofovir—Vomiting—Methotrexate—multiple sclerosis	6.72e-05	0.000666	CcSEcCtD
Tenofovir—ABCC4—Platelet degranulation—TGFB1—multiple sclerosis	6.67e-05	0.00121	CbGpPWpGaD
Tenofovir—Rash—Methotrexate—multiple sclerosis	6.66e-05	0.000661	CcSEcCtD
Tenofovir—Dermatitis—Methotrexate—multiple sclerosis	6.66e-05	0.00066	CcSEcCtD
Tenofovir—Headache—Methotrexate—multiple sclerosis	6.62e-05	0.000656	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.55e-05	0.00119	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	6.47e-05	0.00118	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	6.35e-05	0.00116	CbGpPWpGaD
Tenofovir—AK2—Metabolism—APOE—multiple sclerosis	6.34e-05	0.00115	CbGpPWpGaD
Tenofovir—Nausea—Methotrexate—multiple sclerosis	6.28e-05	0.000622	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.04e-05	0.0011	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.79e-05	0.00105	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.73e-05	0.00104	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.71e-05	0.00104	CbGpPWpGaD
Tenofovir—NME1—Metabolism—BCHE—multiple sclerosis	5.54e-05	0.00101	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.53e-05	0.00101	CbGpPWpGaD
Tenofovir—AK2—Metabolism—POMC—multiple sclerosis	5.45e-05	0.000991	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.04e-05	0.000918	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ALB—multiple sclerosis	4.97e-05	0.000904	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.89e-05	0.000889	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ITGA4—multiple sclerosis	4.88e-05	0.000888	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNB1—multiple sclerosis	4.84e-05	0.000881	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	4.74e-05	0.000862	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	4.67e-05	0.00085	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.61e-05	0.000838	CbGpPWpGaD
Tenofovir—NME2—Metabolism—APOE—multiple sclerosis	4.4e-05	0.0008	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	4.32e-05	0.000786	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.28e-05	0.000779	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.23e-05	0.000769	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.21e-05	0.000766	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	4.12e-05	0.000749	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	3.79e-05	0.00069	CbGpPWpGaD
Tenofovir—NME2—Metabolism—POMC—multiple sclerosis	3.78e-05	0.000687	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.73e-05	0.000679	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.57e-05	0.00065	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	3.47e-05	0.000632	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ALB—multiple sclerosis	3.44e-05	0.000627	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.39e-05	0.000616	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.39e-05	0.000616	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2RA—multiple sclerosis	3.33e-05	0.000606	CbGpPWpGaD
Tenofovir—NME1—Metabolism—APOE—multiple sclerosis	3.33e-05	0.000606	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.29e-05	0.000599	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.29e-05	0.000598	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.22e-05	0.000586	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.07e-05	0.000558	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.07e-05	0.000558	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	2.96e-05	0.000538	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.9e-05	0.000528	CbGpPWpGaD
Tenofovir—NME1—Metabolism—POMC—multiple sclerosis	2.86e-05	0.000521	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALB—multiple sclerosis	2.61e-05	0.000475	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—ALB—multiple sclerosis	2.41e-05	0.000438	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.18e-05	0.000396	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SRM—multiple sclerosis	2.14e-05	0.000389	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.09e-05	0.000379	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.98e-05	0.000361	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2—multiple sclerosis	1.95e-05	0.000355	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.82e-05	0.00033	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.76e-05	0.00032	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TGFB1—multiple sclerosis	1.52e-05	0.000277	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.51e-05	0.000274	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.51e-05	0.000274	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK1—multiple sclerosis	1.49e-05	0.000272	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.47e-05	0.000268	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.38e-05	0.000251	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.14e-05	0.000208	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.87e-06	0.000161	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.62e-06	0.000139	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.94e-06	0.000126	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.56e-06	0.000119	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—APOE—multiple sclerosis	3.95e-06	7.18e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—POMC—multiple sclerosis	3.39e-06	6.17e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALB—multiple sclerosis	3.09e-06	5.63e-05	CbGpPWpGaD
